Literature DB >> 20550777

Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection.

R M G J Houben1, J R Glynn, K Mallard, L Sichali, S Malema, P E M Fine, N French, A C Crampin.   

Abstract

BACKGROUND: Human immunodeficiency virus associated tuberculosis (TB) disease can follow reactivation of latent Mycobacterium tuberculosis infection or recent (re-)infection with M. tuberculosis. If contemporary TB cases share identical M. tuberculosis strains (i.e., are 'clustered'), the episode is likely to have followed recent (re-)infection, irrespective of evidence of previous latent infection.
METHODS: Individuals experiencing a first TB episode between 1996 and 2008 in Karonga District, Northern Malawi, were included if information on M. tuberculosis infection status (from tuberculin tests) before 1990 and a DNA fingerprint from the TB episode were available. We explored differences in proportion clustered by prior M. tuberculosis infection status and HIV status, adjusting for age, sex, bacille Calmette-Guérin scar status and time since tuberculin testing.
RESULTS: Of 79 HIV-negative TB cases, those with previous M. tuberculosis infection were much less likely to be clustered than cases without prior infection (29% vs. 77%, adjusted OR = 0.15, 95%CI 0.04-0.59). Among 119 HIV-positive TB cases, clustering was similar in both groups (88% vs. 84%, adjusted OR = 1.85, 95%CI 0.41-8.29). DISCUSSION: HIV infection appears to increase the risk of TB following recent re-infection in patients with latent M. tuberculosis infection. Our results add to the mounting evidence that HIV-associated TB mainly follows recent M. tuberculosis infection.

Entities:  

Mesh:

Year:  2010        PMID: 20550777      PMCID: PMC3276831     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  26 in total

1.  Trends in tuberculosis and the influence of HIV infection in northern Malawi, 1988-2001.

Authors:  Judith R Glynn; Amelia C Crampin; Bagrey M M Ngwira; Frank D Mwaungulu; Donex T Mwafulirwa; Sian Floyd; Jörg M Pönnighaus; David K Warndorff; Paul E M Fine
Journal:  AIDS       Date:  2004-07-02       Impact factor: 4.177

2.  Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis.

Authors:  G Canetti; I Sutherland; E Svandova
Journal:  Bull Int Union Tuberc       Date:  1972-02

3.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers.

Authors:  P Sonnenberg; J Murray; J R Glynn; S Shearer; B Kambashi; P Godfrey-Faussett
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

4.  Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys.

Authors:  H L Rieder
Journal:  Tuber Lung Dis       Date:  1995-04

5.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.

Authors:  P E Fine; J A Sterne; J M Pönnighaus; R J Rees
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

7.  Tuberculosis and gender: exploring the patterns in a case control study in Malawi.

Authors:  A C Crampin; J R Glynn; S Floyd; S S Malema; V K Mwinuka; B M M Ngwira; F D Mwaungulu; D K Warndorff; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2004-02       Impact factor: 2.373

Review 8.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

9.  The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands.

Authors:  I Sutherland; E Svandová; S Radhakrishna
Journal:  Tubercle       Date:  1982-12

10.  Exogenous reinfection in experimental airborne tuberculosis.

Authors:  J E Ziegler; M L Edwards; D W Smith
Journal:  Tubercle       Date:  1985-06
View more
  11 in total

Review 1.  Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.

Authors:  Jason R Andrews; Farzad Noubary; Rochelle P Walensky; Rodrigo Cerda; Elena Losina; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

Review 2.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

Review 3.  A systematic review of published literature describing factors associated with tuberculosis recurrence in people living with HIV in Africa.

Authors:  Yoshan Moodley; Kumeren Govender
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

4.  Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases.

Authors:  Ifedayo M O Adetifa; Martin O C Ota; Brigitte Walther; Abdulrahman S Hammond; Moses D Lugos; David J Jeffries; Simon A Donkor; Richard A Adegbola; Philip C Hill
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

5.  Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.

Authors:  Emily A Kendall; Andrew S Azman; Gary Maartens; Andrew Boulle; Robert J Wilkinson; David W Dowdy; Molebogeng X Rangaka
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.177

6.  Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area.

Authors:  J A Guerra-Assunção; A C Crampin; R M G J Houben; T Mzembe; K Mallard; F Coll; P Khan; L Banda; A Chiwaya; R P A Pereira; R McNerney; P E M Fine; J Parkhill; T G Clark; J R Glynn
Journal:  Elife       Date:  2015-03-03       Impact factor: 8.140

7.  Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.

Authors:  R Ragonnet; J M Trauer; E S McBryde; R M G J Houben; J T Denholm; A Handel; T Sumner
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

8.  Infection of multiple Mycobacterium tuberculosis strains among tuberculosis/human immunodeficiency virus co-infected patients: A molecular study in Myanmar.

Authors:  Myo Su Kyi; Prasit Palittapongarnpim; Angkana Chaiprasert; Pravech Ajawatanawong; H Ctor Guzmán GarcIa; Virasakdi Chongsuvivatwong
Journal:  Int J Mycobacteriol       Date:  2018 Oct-Dec

9.  Profiling the mRNA and miRNA in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis.

Authors:  Dan Cao; Ju Wang; Zhongkang Ji; Yanwan Shangguan; Wanru Guo; Xuewen Feng; Kaijin Xu; Jiezuan Yang
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

10.  Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.

Authors:  Rein M G J Houben; Tom Sumner; Alison D Grant; Richard G White
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.